{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:48:20Z","timestamp":1781585300076,"version":"3.54.5"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Patients with septic shock caused by <jats:italic>Staphylococcus aureus<\/jats:italic> have mortality rates exceeding 50%, despite appropriate antibiotic therapy. Our objectives were to establish a rabbit model of <jats:italic>S. aureus<\/jats:italic> septic shock and to determine whether a novel immunotherapy can prevent or halt its natural disease progression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Anesthetized rabbits were ventilated with lung-protective low-tidal volume, instrumented for advanced hemodynamic monitoring, and characterized for longitudinal changes in acute myocardial dysfunction by echocardiography and sepsis-associated biomarkers after <jats:italic>S. aureus<\/jats:italic> intravenous challenge. To demonstrate the potential utility of this hyperdynamic septic shock model for preclinical drug development, rabbits were randomized for prophylaxis with anti-Hla\/Luk\/ClfA monoclonal antibody combination that neutralizes alpha-hemolysin (Hla), the bicomponent pore-forming leukocidins (Luk) including Panton-Valentine leukocidin, leukocidin ED, and gamma-hemolysin, and clumping factor A (ClfA), or an irrelevant isotype-matched control IgG (c-IgG), and then challenged with <jats:italic>S. aureus<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Rabbits challenged with <jats:italic>S. aureus<\/jats:italic>, but not those with saline, developed a hyperdynamic state of septic shock characterized by elevated cardiac output (CO), increased stroke volume (SV) and reduced systemic vascular resistance (SVR), which was followed by a lethal hypodynamic state characterized by rapid decline in mean arterial pressure (MAP), increased central venous pressure, reduced CO, reduced SV, elevated SVR, and reduced left-ventricular ejection fraction, thereby reproducing the hallmark clinical features of human staphylococcal septic shock. In this model, rabbits pretreated with anti-Hla\/Luk\/ClfA mAb combination had 69% reduction in mortality when compared to those pretreated with c-IgG (<jats:italic>P<\/jats:italic>&amp;lt;0.001). USA300-induced acute circulatory failure\u2014defined as &amp;gt;70% decreased in MAP from pre-infection baseline\u2014occurred in only 20% (2\/10) of rabbits pretreated with anti-Hla\/Luk\/ClfA mAb combination compared to 100% (9\/9) of those pretreated with c-IgG. Prophylaxis with anti-Hla\/Luk\/ClfA mAb combination halted progression to lethal hypodynamic shock, as evidenced by significant protection against the development of hyperlactatemia, hypocapnia, hyperkalemia, leukopenia, neutropenia, monocytopenia, lymphopenia, as well as biomarkers associated with acute myocardial injury.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These results demonstrate the potential utility of a mechanically ventilated rabbit model that reproduced hallmark clinical features of hyperdynamic septic shock and the translational potential of immunotherapy targeting <jats:italic>S. aureus<\/jats:italic> virulence factors for the prevention of staphylococcal septic shock.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1260627","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T05:50:43Z","timestamp":1695016243000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Monoclonal antibodies neutralizing alpha-hemolysin, bicomponent leukocidins, and clumping factor A protected against Staphylococcus aureus-induced acute circulatory failure in a mechanically ventilated rabbit model of hyperdynamic septic shock"],"prefix":"10.3389","volume":"14","author":[{"given":"Nhu T. Q.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thien N. M.","family":"Doan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Tkaczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bret R.","family":"Sellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binh An","family":"Diep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6809e1","article-title":"Vital signs: Epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible staphylococcus aureus bloodstream infections - United States","volume":"68","author":"Kourtis","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.15.1763","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections in the United States","volume":"298","author":"Klevens","year":"2007","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.05022-11","article-title":"Predictors of mortality in Staphylococcus aureus Bacteremia","volume":"25","author":"van Hal","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw581","article-title":"Staphylococcus aureus in the intensive care unit: Are these golden grapes ripe for a new approach","volume":"215","author":"Sampedro","year":"2017","journal-title":"J Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-012615-044351","article-title":"Pathogenesis of Staphylococcus aureus bloodstream infections","volume":"11","author":"Thomer","year":"2016","journal-title":"Annu Rev Pathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrmicro3161","article-title":"Adhesion, invasion and evasion: the many functions of the surface proteins of","volume":"12","author":"Foster","year":"2013","journal-title":"Staphylococcus aureus. Nat Rev Microbiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro.2017.27","article-title":"Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors","volume":"15","author":"Spaan","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.3010","article-title":"Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial","volume":"309","author":"Fowler","year":"2013","journal-title":"JAMA"},{"key":"B9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/1469-0691.12570","article-title":"Where does a","author":"Fowler","year":"2014","journal-title":"Staphylococcus aureus Vaccine stand? Clin Microbiol Infect"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4161\/hv.34414","article-title":"Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study","volume":"11","author":"Fattom","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuz030","article-title":"Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms","volume":"44","author":"Miller","year":"2020","journal-title":"FEMS Microbiol Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01213-16","article-title":"Improved Protection in a Rabbit Model of Community-Associated Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia upon Neutralization of Leukocidins in Addition to Alpha-Hemolysin","volume":"60","author":"Diep","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"B13","unstructured":"ReleaseAN\n          Arsanis provides update following completion of planned interim analysis of phase 2 clinical trial of ASN1002018"},{"key":"B14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/femsre\/fuz030","article-title":"Development of a vaccine against Staphylococcus aureus invasive infections: Evidence-based on human immunity, genetics, and bacterial evasion mechanisms","volume":"44","author":"Miller","year":"2020","journal-title":"FEMS Microbiol Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30995-6","article-title":"Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial","volume":"21","author":"Francois","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00346-19","article-title":"Efficacy of a Multimechanistic Monoclonal Antibody Combination against Staphylococcus aureus Surgical Site Infections in Mice","volume":"63","author":"Ortines","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00130-22","article-title":"Neutralizing Staphylococcus aureus Virulence with AZD6389, a Three mAb Combination, Accelerates Closure of a Diabetic Polymicrobial Wound","volume":"7","author":"Tkaczyk","year":"2022","journal-title":"mSphere"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01832-20","article-title":"Multi-mechanistic monoclonal antibody combination targeting key Staphylococcus aureus virulence determinants in a rabbit model of prosthetic joint infection","volume":"65","author":"Mao","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0912403107","article-title":"Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury","volume":"107","author":"Diep","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000715","article-title":"Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils","volume":"6","author":"Loffler","year":"2010","journal-title":"PLoS Pathog"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.5.1659-1665.1996","article-title":"Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge","volume":"64","author":"Fattom","year":"1996","journal-title":"Infect Immun"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.74.4.2215-2223.2006","article-title":"A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S","volume":"74","author":"Kuklin","year":"2006","journal-title":"aureus sepsis Model Infect Immun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.02.097","article-title":"IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge","volume":"28","author":"Kim","year":"2010","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4161\/hv.18946","article-title":"Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17\/IL17 pathway in a murine sepsis model","volume":"8","author":"Joshi","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011297","article-title":"Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis","volume":"346","author":"Shinefield","year":"2002","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1965.01320130123014","article-title":"Hemodynamic measurements in septic shock","volume":"91","author":"Wilson","year":"1965","journal-title":"Arch Surg"},{"key":"B27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1378\/chest.85.1.75","article-title":"Sequential cardiorespiratory patterns associated with outcome in septic shock","volume":"85","author":"Abraham","year":"1984","journal-title":"Chest"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/bja\/aep339","article-title":"Sepsis and the heart","volume":"104","author":"Hunter","year":"2010","journal-title":"Br J Anaesth"},{"key":"B29","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1161\/CIRCULATIONAHA.106.678359","article-title":"Sepsis and the heart","volume":"116","author":"Merx","year":"2007","journal-title":"Circulation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/SHK.0000000000001209","article-title":"Huber-lang M. Part III: Minimum quality threshold in preclinical sepsis studies (MQTiPSS) for fluid resuscitation and antimicrobial therapy endpoints","volume":"51","author":"Hellman","year":"2019","journal-title":"Shock"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.5.2010073","article-title":"Characterization of a hyperdynamic murine model of resuscitated sepsis using echocardiography","volume":"164","author":"Hollenberg","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-008-1360-9","article-title":"Fluid resuscitation influences cardiovascular performance and mortality in a murine model of sepsis","volume":"35","author":"Zanotti-Cavazzoni","year":"2009","journal-title":"Intensive Care Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112559","article-title":"Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock","volume":"78","author":"Natanson","year":"1986","journal-title":"J Clin Invest"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1982.243.1.R131","article-title":"Hyperdynamic severe intravascular sepsis depends on fluid administration in cynomolgus monkey","volume":"243","author":"Carroll","year":"1982","journal-title":"Am J Physiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02724-20","article-title":"Pseudomonas aeruginosa ventilator-associated pneumonia rabbit model for preclinical drug development","volume":"65","author":"Nguyen","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01983-20","article-title":"FDA public workshop summary: Advancing animal models for antibacterial drug development","volume":"65","author":"Byrne","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02190-13","article-title":"Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia","volume":"58","author":"Hua","year":"2014","journal-title":"Antimicrobial Agents chemother"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00629-17","article-title":"Multimechanistic monoclonal antibodies (MAbs) targeting Staphylococcus aureus alpha-toxin and clumping factor A: Activity and efficacy comparisons of a MAb combination and an engineered bispecific antibody approach","volume":"61","author":"Tkaczyk","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-196606000-00008","article-title":"Circulatory and metabolic alterations associated with survival or death in peritonitis: clinical analysis of 25 cases","volume":"163","author":"Clowes","year":"1966","journal-title":"Ann Surg"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318174db05","article-title":"Actual incidence of global left ventricular hypokinesia in adult septic shock","volume":"36","author":"Vieillard-Baron","year":"2008","journal-title":"Crit Care Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003198","article-title":"Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis","volume":"3","author":"Diep","year":"2008","journal-title":"PLoS One"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.5669","article-title":"Acute respiratory distress syndrome: the Berlin Definition","volume":"307","author":"Force","year":"2012","journal-title":"JAMA"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000132904.35713.A7","article-title":"Early lactate clearance is associated with improved outcome in severe sepsis and septic shock","volume":"32","author":"Nguyen","year":"2004","journal-title":"Crit Care Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1971.00310160209017","article-title":"Acid-base balance in bacteremic shock","volume":"127","author":"Blair","year":"1971","journal-title":"Arch Intern Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(70)90146-7","article-title":"Hypocapnia and gram-negative bacteremic shock","volume":"119","author":"Blair","year":"1970","journal-title":"Am J Surg"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(74)90475-6","article-title":"Extreme hypocapnia in the critically ill patient","volume":"56","author":"Mazzara","year":"1974","journal-title":"Am J Med"},{"key":"B47","article-title":"The de ritis ratio: the test of time","volume":"34","author":"Botros","year":"2013","journal-title":"Clin Biochem Rev"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181a590da","article-title":"Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systematic review of the literature","volume":"37","author":"Marik","year":"2009","journal-title":"Crit Care Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.6.2000","article-title":"Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence","volume":"121","author":"Michard","year":"2002","journal-title":"Chest"},{"key":"B51","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s13054-014-0503-3","article-title":"Sepsis-associated hyperlactatemia","volume":"18","author":"Garcia-Alvarez","year":"2014","journal-title":"Crit Care"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.12.63","article-title":"The complete blood count to diagnose septic shock","volume":"12","author":"Farkas","year":"2020","journal-title":"J Thorac Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N Engl J Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"329ra331","DOI":"10.1126\/scitranslmed.aad9922","article-title":"Staphylococcus aureus alpha toxin potentiates opportunistic bacterial lung infections","volume":"8","author":"Cohen","year":"2016","journal-title":"Sci Transl Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02456-16","article-title":"Targeting alpha toxin to mitigate its lethal toxicity in ferret and rabbit models of Staphylococcus aureus necrotizing pneumonia","volume":"61","author":"Diep","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02220-19","article-title":"Protective efficacy of monoclonal antibodies neutralizing alpha-hemolysin and bicomponent leukocidins in a rabbit model of Staphylococcus aureus necrotizing pneumonia","volume":"64","author":"Vu","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.05589-11","article-title":"Identification of anti-alpha toxin monoclonal antibodies that reduce the severity of Staphylococcus aureus dermonecrosis and exhibit a correlation between affinity and potency","volume":"19","author":"Tkaczyk","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00710-16","article-title":"Critical role of alpha-toxin and protective effects of its neutralization by a human antibody in acute bacterial skin and skin structure infections","volume":"60","author":"Le","year":"2016","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1260627\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T05:50:46Z","timestamp":1695016246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1260627\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":58,"alternative-id":["10.3389\/fimmu.2023.1260627"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1260627","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]},"article-number":"1260627"}}